REPOCEUTICALS A/S: Financial statements 2019
CVR: 36494433
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
REPOCEUTICALS A/S (CVR 36494433) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK -523,215 compared with DKK -383,311 the year before. Equity in the 2019 report amounted to DKK 6,041,717. The solvency ratio was 74.1%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -523,215
- Equity
- DKK 6,041,717
- Total Assets
- DKK 8,154,080
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 0 | 0 | -523K | 6M | - |
| 2018 | 0 | 0 | -383K | -356K | - |
| 2017 | - | - | -78K | 27K | - |
| 2016 | - | - | -211K | 105K | - |
| 2015 | - | - | -34K | 316K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of June 18, 2019, Troels Peter Troelsen has joined the board of directors of REPOCEUTICALS A/S.
As of June 18, 2019, Preben Møllegaard Grundtvig has joined the board of directors of REPOCEUTICALS A/S.
As of June 18, 2019, Henrik Bulskov has joined the board of directors of REPOCEUTICALS A/S.
As of June 18, 2019, Sigbjørn Georg Nielsen Kjærgård has joined the board of directors of REPOCEUTICALS A/S.
As of June 18, 2019, Nete Søgaard Poulsen has joined the board of directors of REPOCEUTICALS A/S.
As of June 18, 2019, Charlotte Pahl has joined the board of directors of REPOCEUTICALS A/S.
On June 18, 2019, the company changed its name from REPOCEUTICALS ApS to REPOCEUTICALS A/S.
REPOCEUTICALS A/S has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -383,311.
As of May 22, 2019, NIELS ERIK JESPERSEN HOLDING ApS is registered as an owner of REPOCEUTICALS A/S with an ownership share of 10%.
About REPOCEUTICALS A/S
REPOCEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPOCEUTICALS ApS. The management consists of Torsten Bjørn. The board consists of Henrik Bulskov (chair), Charlotte Pahl and Christian Vinding Thomsen. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and DMZ HOLDING ApS. The company has 2 employees (2026). In 2025, the company reported revenue of DKK 88,000,000 and a net result of DKK -6,228,938,000 compared with DKK -6,274,548 the year before. Equity in the 2025 report amounted to DKK 6,245,088,000.